Regulus Therapeutics Stock (NASDAQ: RGLS) stock price, news, charts, stock research, profile.
Open | $2.100 |
Close | $2.080 |
Volume / Avg. | 568.234K / 3.159M |
Day Range | 2.010 - 2.170 |
52 Wk Range | 1.080 - 3.790 |
Market Cap | $136.824M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 12.18% |
Days to Cover | 15.82 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Regulus Therapeutics (NASDAQ: RGLS) through any online brokerage.
Other companies in Regulus Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), CytomX Therapeutics (NASDAQ:CTMX), FibroGen (NASDAQ:FGEN), Vistagen Therapeutics (NASDAQ:VTGN) and Tevogen Bio Holdings (NASDAQ:TVGN).
The latest price target for Regulus Therapeutics (NASDAQ: RGLS) was reported by HC Wainwright & Co. on Friday, May 10, 2024. The analyst firm set a price target for 9.00 expecting RGLS to rise to within 12 months (a possible 330.62% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $2.09 last updated May 14, 2024 at 8:32 AM EDT.
There are no upcoming dividends for Regulus Therapeutics.
Regulus Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Regulus Therapeutics.
Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.